{
    "clinical_study": {
        "@rank": "122525", 
        "arm_group": [
            {
                "arm_group_label": "vaccine without gelatin", 
                "arm_group_type": "Experimental", 
                "description": "use the upper arm flank deltoid muscle adheres to stick cohere place the skin after 75% ethyl alcohol disinfection the hypodermic injection"
            }, 
            {
                "arm_group_label": "vaccine with gelatin", 
                "arm_group_type": "Active Comparator", 
                "description": "use the upper arm flank deltoid muscle adheres to stick cohere place the skin after 75% ethyl alcohol disinfection the hypodermic injection"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to observe the occurrence of adverse reaction and antibody\n      positive rate, the elevated level of antibody\uff0cGeometric mean titer (GMT) between groups of\n      live attenuated varicella vaccine without gelatin."
        }, 
        "brief_title": "Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin", 
        "completion_date": {
            "#text": "January 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Chickenpox", 
            "Zoster"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Chickenpox", 
                "Herpes Zoster"
            ]
        }, 
        "detailed_description": {
            "textblock": "Observational Objectives:\n\n      To describe the safety of evaluated vaccine, in children aged \u2265 1th birthday and \u2264 12th\n      birthday.\n\n      To describe the immunogenicity of evaluated vaccine, in children aged \u2265 1th birthday and \u2264\n      12th birthday."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Parent/legal acceptable representative is willing and able to understand the protocol\n             requirements and provide informed consent\n\n          -  Participant is considered to be in good health including the body and mental status\n             on the basis of reported medical history and limited physical examination and live in\n             local \u2265 12 months\n\n          -  Participant is aged \u2265 1 year to \u2264 12 years\n\n          -  Body temperature \u2264 37.0\u2103\n\n          -  Participant without preventive inoculation of varicella vaccine and previous history\n             of chickenpox and zoster\n\n        Exclusion Criteria:\n\n          -  Known allergy to any constituent of the vaccine\n\n          -  Reported the history of allergies, convulsions, epilepsy, mental illness and brain\n             disease and clear serious systemic reaction\n\n          -  Known bleeding disorder\n\n          -  Known or suspected impairment of immunologic function, or receipt of\n             immunosuppressive therapy or immunoglobulin since birth\n\n          -  Participation in any other interventional clinical trial\n\n          -  An acute illness with or without fever (temperature \uff1e 37.0\u2103) in the latest week\n             preceding enrollment in the trial\n\n          -  Inoculated other vaccines, immunoglobulin or investigational drugs within 4 weeks\n             prior to participation in the study\n\n          -  Reported clearly the infection of the upper respiratory tract with 6 months\n\n          -  Clinical Manifestation of Metabolic, blood system, lungs, heart, the gastrointestinal\n             tract, nervous system, kidneys, urinary system, endocrine, liver disease or malignant\n             tumor\n\n          -  Any condition which, in the opinion of the investigator, would pose a health risk to\n             the subject or interfere with the vaccine"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "12 Years", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "1200", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 9, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01684072", 
            "org_study_id": "BJCDPC-2"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "vaccine without gelatin", 
                    "vaccine with gelatin"
                ], 
                "description": "use the upper arm flank deltoid muscle adheres to stick cohere place the skin after 75% ethyl alcohol disinfection the hypodermic injection", 
                "intervention_name": "vaccine without gelatin", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": [
                    "vaccine without gelatin", 
                    "vaccine with gelatin"
                ], 
                "description": "use the upper arm flank deltoid muscle adheres to stick cohere place the skin after 75% ethyl alcohol disinfection the hypodermic injection", 
                "intervention_name": "vaccine with gelatin", 
                "intervention_type": "Biological"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Ethanol"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "varicella vaccine", 
            "gelatin"
        ], 
        "lastchanged_date": "September 9, 2012", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing"
                    }, 
                    "name": "Chaoyang District Center for Disease Control and Prevention"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Langfang", 
                        "country": "China", 
                        "state": "Hebei"
                    }, 
                    "name": "Sanhe Center for Disease Control and Prevention"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baotou", 
                        "country": "China", 
                        "state": "Inner Mongolia"
                    }, 
                    "name": "Jiuyuan Center for Disease Control and Prevention"
                }
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluation of Safety and Immunogenicity Receiving Live Attenuated Vaccine Against Varicella Without Gelatin", 
        "overall_official": {
            "affiliation": "Beijing Chaoyang District Center for Disease Control and Prevention", 
            "last_name": "Nianmin Shi", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "September 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The immunologic equivalence of 4weeks after vaccination of influenza virus vaccine was measured in terms of the level of antibody.", 
            "measure": "To evaluate the immunogenicity of evaluated vaccine", 
            "safety_issue": "No", 
            "time_frame": "8 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01684072"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The incidence of adverse events was analyzed statistically.", 
            "measure": "To evaluate the safety of live attenuated varicella vaccine", 
            "safety_issue": "Yes", 
            "time_frame": "4 months"
        }, 
        "source": "Beijing Center for Disease Control and Prevention", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Beijing Center for Disease Control and Prevention", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}